| Name | Title | Contact Details |
|---|
Precision Biopsy, LLC was formed in partnership with Allied Minds to develop and commercialize novel technology for the accurate diagnosis of prostate cancer. The company’s diagnostic technology uses advanced spectroscopy imaging techniques in combination with tissue biopsy. For the first time, this unique ability will eliminate random prostate biopsies that are subject to sampling errors and can lead to inaccurate grading and staging of the disease. The scientific founders, professors Priya Werahara and John Daily of the University of Colorado, have long studied the morphology of cancer tissue. Combining their knowledge of advanced spectroscopy techniques has resulted in the ability to image the precise location of cancer in the prostate.
ABB OPTICAL GROUP is dedicated to being the premier optical industry platform - our mission is to deliver tailored business solutions and world class customer service, to help each eye care practitioner to exceed their patient`s expectations. Our dynamic vision care organization supplies 30,000 eye care professionals, retail stores, hospitals and universities, with brand name contact lenses and finished ophthalmic lenses and manufactures fully customizable gas permeable and custom specialty soft lenses. In addition, our Digital Eye Lab provides eye care professionals with digitally surfaced freeform ophthalmic lens designs and AR coatings. ABB also offers practice building tools such as pricing strategy tools, business reviews, annual supply staff training and ecommerce solutions, including patient ordering websites yourlens.com and primaryecp.com. ABB OPTICAL GROUP is a New Mountain Capital portfolio company, formed through the merger of ABB CONCISE Optical Group and Optical Distributor Group.
Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.
Korman Healthcare is a Chandler, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Phadia US is a Portage, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.